Courcouronnes, France

Michel Homerin

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Michel Homerin: Pioneering Digestive Treatments

Introduction

Michel Homerin, an accomplished inventor based in Courcouronnes, France, has made significant strides in the field of pharmacology. With a robust portfolio of three patents, Homerin's work primarily focuses on the development of novel compounds aimed at improving therapeutic outcomes for digestive pathologies.

Latest Patents

Homerin's latest contributions to the field include two notable patents. The first patent, titled "Enantiomer (-) of tenatoprazole and the therapeutic use thereof," describes an innovative enantiomer (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine. This enantiomer exhibits enhanced pharmacokinetic properties, allowing for a once-a-day dosage regimen for relevant indications. The second patent, "Monohydrated sodium salt of S-tenatoprazole and the use thereof in therapy," highlights the therapeutic application of S-tenatoprazole monohydrated sodium salt for treating digestive diseases. These inventions mark a significant advancement in the management of gastrointestinal disorders.

Career Highlights

Homerin is currently affiliated with Sidem Pharma, where he applies his scientific expertise to contribute to the development of innovative therapeutic solutions. His commitment to enhancing patient care through groundbreaking research has positioned him as a respected figure in the pharmaceutical industry.

Collaborations

Throughout his career, Michel Homerin has collaborated with esteemed colleagues Avraham Cohen and Suzy Charbit. These partnerships have fostered a creative environment for brainstorming and developing novel therapeutic approaches to tackle complex digestive health challenges.

Conclusion

Michel Homerin's dedication to innovation in the pharmaceutical field is commendable. His latest patents not only underscore his inventiveness but also reflect his commitment to improving therapeutic outcomes for patients suffering from digestive disorders. As he continues his work with Sidem Pharma, the potential for further advancements remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…